ReviewProbiotics and antimicrobial proteins2026
Current Status and Future Challenges in the Use of Bacteriocins to Modulate Ruminant Gut Microbiota.
Review in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bacteriocins in Veterinary Medicine: From Antibiotic Limitations to Targeted Solutions.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The overuse of antibiotics is leading to an ever-increasing risk of bacterial resistance in animals and humans. In response, new alternatives are emerging to combat these threats, including the use of bacteriocins. Bacteriocins are small peptides secreted by bacteria and have a remarkable antimicrobial effect, usually with a narrow spectrum of inhibition. These antimicrobial peptides raise new hopes in the fight against multidrug-resistant pathogenic bacteria and have led to several studies in various fields of scientific research. In agriculture, more specifically in cattle production, bacteriocins are an excellent and promising tool for the treatment of mastitis in dairy cows to avoid the overuse of antibiotics. Bacteriocins can also be used to modulate the rumen microbiota to increase feed performance and milk/meat yield. In addition, modulation of rumen microbiota by bacteriocins may reduce methane production and thus the emission of this greenhouse gas by ruminants. This review examines the potential of bacteriocins and bacteriocin-producing bacteria to modulate the rumen microbiota and the resulting effects on ruminant health, productivity, and the reduction of methane emissions.
Indexed as
Identifiers
41066045What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.